Acasti Pharma reported CAD50.94M in Cash and Equivalent for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acasti Pharma ACST:US C$ 50.94M 39.39M
Agile Therapeutics AGRX:US $ 26.12M 9.65M
Amarin AMRN:US $ 327.02M 36.02M
Bioscrip BIOS:US $ 157.53M 48.16M
Pain Therapeutics PTIE:US $ 278.25M 3.94M